4//SEC Filing
Clendeninn Neil James 4
Accession 0001209191-12-031812
CIK 0000949858other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 12:33 PM ET
Size
8.1 KB
Accession
0001209191-12-031812
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Award
Restricted Stock Units
2012-05-31+2,000→ 2,000 total→ Common (2,000 underlying) - Award
Stock Option (right to buy)
2012-05-31+4,000→ 4,000 totalExercise: $12.56Exp: 2022-05-31→ Common (4,000 underlying)
Footnotes (4)
- [F1]The options vest 100% on the earlier of May 31, 2013 or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F4]The restricted stock units expire 30 days from the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders.
Documents
Issuer
ONCOGENEX PHARMACEUTICALS, INC.
CIK 0000949858
Entity typeother
Related Parties
1- filerCIK 0001442443
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 12:33 PM ET
- Size
- 8.1 KB